Online access to suspected side-effect reports

Homepage image

On this website you can view data on suspected side-effects, also known as suspected adverse drug reactions, for authorised medicines in the European Economic Area (EEA).

For centrally authorised medicines, access to reports is granted both by the name of the medicine or the name of the active substance. For non-centrally authorised medicines, access is granted based on the name of the active substance only.

Please note: the drug treatment duration in the line listing of individual cases might be displayed in days although the reported drug treatment duration was not provided in days but in another unit. We are currently working on resolving this issue.

Key information
bullet The information on this website relates to suspected side effects , i.e. medical events that have been observed following the use of a medicine, but which are not necessarily related to or caused by the medicine.
bullet Information on suspected side effects should not be interpreted as meaning that the medicine or the active substance causes the observed effect or is unsafe to use. Only a detailed evaluation and scientific assessment of all available data allows for robust conclusions to be drawn on the benefits and risks of a medicine.
The European Medicines Agency publishes these data so that its stakeholders, including the general public, can access information that European regulatory authorities use to review the safety of a medicine or active substance. Transparency is a key guiding principle of the Agency.
 EMA
EudraVigilance